Author:
de Sousa Ana Carolina C.,Combrinck Jill M.,Maepa Keletso,Egan Timothy J.
Abstract
AbstractMalaria remains a major public health problem. With the loss of antimalarials to resistance, the malaria burden will likely continue for decades. New antimalarial scaffolds are crucial to avoid cross-resistance. Here, we present the first structure based virtual screening using the β-haematin crystal as a target for new inhibitor scaffolds by applying a docking method. The ZINC15 database was searched for compounds with high binding affinity with the surface of the β-haematin crystal using the PyRx Virtual Screening Tool. Top-ranked compounds predicted to interact with β-haematin were submitted to a second screen applying in silico toxicity and drug-likeness predictions using Osiris DataWarrior. Fifteen compounds were purchased for experimental testing. An NP-40 mediated β-haematin inhibition assay and parasite growth inhibition activity assay were performed. The benzoxazole moiety was found to be a promising scaffold for further development, showing intraparasitic haemozoin inhibition using a cellular haem fractionation assay causing a decrease in haemozoin in a dose dependent manner with a corresponding increase in exchangeable haem. A β-haematin inhibition hit rate of 73% was found, a large enrichment over random screening, demonstrating that virtual screening can be a useful and cost-effective approach in the search for new haemozoin inhibiting antimalarials.
Funder
U.S. Department of Health & Human Services | National Institutes of Health
Publisher
Springer Science and Business Media LLC
Reference46 articles.
1. WHO. World Malaria Report (Geneva) (2017).
2. WHO. Global Report on Antimalarial Drug Efficacy and Drug Resistance (Geneva) (2017).
3. Neftel, K. A., Woodtly, W., Schmid, M., Frick, P. G. & Fehr, J. Amodiaquine induced agranulocytosis and liver damage. Br. Med. J. 292, 721–723 (1986).
4. Combrinck, J. M. et al. Insights into the role of heme in the mechanism of action of antimalarials. ACS Chem. Biol. 8, 133–137 (2013).
5. Buller, R., Peterson, M. L., Almarsson, Ö. & Leiserowitz, L. Quinoline binding site on malaria pigment crystal: a rational pathway for antimalaria drug design. Cryst. Growth Des. 2, 553–562 (2002).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献